Next Article in Journal
Stroke Prevention in Atrial Fibrillation: Latest Clinical Trials and Guidelines
Next Article in Special Issue
A Perspective on the Comparative Antileukemic Activity of 5-Aza-2′-deoxycytidine (Decitabine) and 5-Azacytidine (Vidaza)
Previous Article in Journal
On the Regulatory Approval Pathway of Biosimilar Products
Previous Article in Special Issue
DNA Methylation as Clinically Useful Biomarkers—Light at the End of the Tunnel
Article Menu

Export Article

Pharmaceuticals 2012, 5(4), 369-383; doi:10.3390/ph5040369
Open AccessReview

Notes on Article Versions

Action Date Notes Link
article html file updated 23 January 2013 14:25 CET Original file -
article html file updated 26 January 2013 09:26 CET Update -
article html file updated 29 January 2013 02:38 CET Update -
article html file updated 6 February 2013 06:58 CET Update -
article html file updated 7 February 2013 01:33 CET Update -
article html file updated 7 February 2013 11:33 CET Update -
article xml file uploaded 6 August 2013 16:03 CEST Original file http://www.mdpi.com/1424-8247/5/4/369/xml
article html file updated 6 August 2013 16:03 CEST Update -
article html file updated 16 June 2015 22:56 CEST Update http://www.mdpi.com/1424-8247/5/4/369/html
Pharmaceuticals EISSN 1424-8247 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top